Nu Skin Enterprises, Inc. (NYSE:NUS) Q1 2026 Earnings Call Transcript
Operator: Good day, and thank you for standing by.
Nu Skin Enterprises Inc. (NUS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Prescott Group Capital Management Phil Frohlich | 1,794,608 | $13,064,746 | +4% | 1.3% |
| 2. | Renaissance Technologies Jim Simons | 1,700,496 | $12,379,611 | -3% | 0.02% |
| 3. | AQR Capital Management Cliff Asness | 1,236,338 | $8,876,909 | +55% | 0% |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 1,012,133 | $7,368,328 | +34% | 0.01% |
| 5. | CastleKnight Management Aaron Weitman | 965,433 | $7,028,352 | +15% | 0.12% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.61 | 5,500 | $52,855.00 | 167,565 | 2025-11-11 | Filing | |
| $7.54 | 6,500 | $49,010.00 | 162,065 | 2025-05-28 | Filing | |
| $49.48 | 5,055 | $250,121.40 | 10,010 | 2021-02-18 | Filing | |
| $49.49 | 5,055 | $250,171.95 | 85,812 | 2021-02-18 | Filing | |
| $50.69 | 4,955 | $251,168.95 | 4,955 | 2021-02-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.73 | 2,676 | $18,009.48 | 30,473 | 2026-05-11 | Filing | |
| $12.22 | 6,489 | $79,295.58 | 33,149 | 2025-09-04 | Filing | |
| $11.97 | 20,000 | $239,400.00 | 233,140 | 2025-09-03 | Filing | |
| $12.10 | 23,391 | $283,031.10 | 53,375 | 2025-08-29 | Filing | |
| $12.12 | 9,046 | $109,637.52 | 39,216 | 2025-08-29 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,291,263 | $31,240,392 | 0% | |
| 2. | 2,143,294 | $15,603,180 | 0% | |
| 3. | 2,063,350 | $15,021,188 | 0% | |
| 4. | 2,021,202 | $14,714,355 | 0.01% | |
| 5. | 1,735,182 | $12,631,879 | 0% |
News See All
Should You Sell Your Stake in Nu Skin Enterprises (NUS)?
Aristotle Capital Boston, LLC, an investment advisor, released its fourth-quarter investor letter for “Small Cap Equity Fund”. A copy of the letter can be downloaded here. U.S.
Nu Skin Enterprises, Inc. (NYSE:NUS) Q4 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q4 2025 Conference Call. At this time, all participants are in a listen-only mode.
Nu Skin Enterprises, Inc. (NYSE:NUS) Q3 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q3 2025 Nu Skin Enterprises Earnings Conference Call.
Nu Skin Enterprises, Inc. (NYSE:NUS) Q2 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q2 2025 Nu Skin Enterprises Earnings Conference Call.
Was Jim Cramer Right About These 10 Stocks?
During the latest episode of Mad Money, which aired on May 13th, Jim Cramer unpacked the extraordinary rebound in U.S.
Nu Skin Enterprises, Inc. (NYSE:NUS) Q1 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q1 2025 Nu Skin Enterprises Earnings Conference Call. At this time, all participants are in a listen-only mode.
12 Best Cosmetics Stocks to Buy for 2025
According to Grand View Research, the global cosmetics industry has a market size of around $295.95 billion as of 2023.
12 Best Household Stocks to Buy According to Hedge Funds
On March 21, Bryan Spillane, Bank of America Securities' senior food and beverage analyst, appeared on CNBC's 'The Exchange' to discuss things across his space and the trends surrounding consumer staples...
Why These 15 Defensive Stocks Are Surging In 2025
Defensive stocks are surging as investors have been shifting their focus. Growth stocks dominated the past two years.
Hedge Fund Resource Center